Page 19 - GPD-2-3
P. 19

Gene & Protein in Disease                                           Signatures construction strategies for TC













































            Figure 1. The flowchart of articles screening.

            In recent years, many signatures have been established   main strategies for constructing prognostic signatures for
            according to different research objectives and methods,   TC were summarized.
            including glucose metabolism , splicing events [51,52] , gene
                                    [50]
            mutations , and chromosomal alteration .           3.3.1. Strategy 1: Signatures based on differentially
                                             [54]
                    [53]
                                                               expressed genes
              Occasionally, some studies contained two or more
            types of signatures. For instance, Li et al. constructed two   In strategy 1, signatures were mainly constructed through
            prognostic signatures (Lnc2mi1m2 and Lnc5m4) which   the following steps (Figure  3): (1) The selection and
            were  capable  of  efficiently  predicting  the  long-term  OS   classification of research objects. Mostly, samples were
            of TC patients . Wang et al. established three different   selected as tumor tissues derived from TC patients and
                        [55]
            types of signatures including a 6-mRNA-based classifier,   normal  tissues  derived  from  paracancerous  tissues  or
            a 5-lncRNA-based classifier, and a 4-miRNA-based   other healthy people [29,40,44] . Ruiz et al. defined differentially
            classifier , to develop a comprehensive and reliable model   expressed genes (DEGs) between N0 and N1 (N0 means
                   [56]
            for predicting the prognosis of TC patients. The predictive   no lymph node metastasis; N1 means primary lymph node
                                                                               [20]
            ability and accuracy of signatures might be improved by   metastasis) samples . You  et al. divided the data from
            employing multiple types of prognosis signatures as well as   TCGA into three groups: (i) Tumor and normal samples;
            constituting a network.                            (ii) PTC samples with or without lymph node metastasis;
                                                               and (iii) PTC samples with stages 1 – 2 and stages 3 – 4 ;
                                                                                                           [33]
            3.3. The strategies for signature construction     (2) identification of differentially expressed mRNAs/
            For diverse research objectives, based on different data   lncRNAs/miRNAs. By comparing the different sample
            sources and platforms, researchers usually preferred   groups mentioned above, most authors applied edgeR
            different research and analysis methods to construct   to identify differentially expressed mRNAs/lncRNAs/
            prognostic labels. Through comprehensive analysis, three   miRNAs. Teng et al. used the Bioconductor package edgeR


            Volume 2 Issue 3 (2023)                         3                        https://doi.org/10.36922/gpd.1138
   14   15   16   17   18   19   20   21   22   23   24